Printed from: Martindale: The Complete Drug Reference. [online] London: Pharmaceutical Press. < http://www.medicinescomplete.com/ > [Accessed on 24 Apr 2014 (GMT)].

What's new?

12 Mar 2014: Martindale March 2014 update

This update contains 10 new monographs and over 150 existing monographs have been updated. Pharmacopoeial information has been updated to reflect the BP and BP Vet 2014 and Ph Eur 8.0, preparations updated for 4 countries, and information related to driving, and referenced to the UK DVLA, revised. The use of tables and figures has been expanded for this update to improve the representation of this information; a further 20 tables and 7 figures that are printed in Martindale are now also available online.

New monographs:

  • Acotiamide Hydrochloride: is an inhibitor of peripheral anticholinesterase activity; it is used in the symptomatic relief of functional dyspepsia
  • Bedaquiline: is an oral antimycobacterial that is used as part of combination therapy, with at least 3 other antituberculous drugs, in the treatment of multidrug-resistant pulmonary tuberculosis when an effective treatment regimen cannot otherwise be provided
  • Daclatasvir: is an oral replication complex inhibitor of hepatitis C virus protein NS5A that is used with other antivirals for the treatment of chronic hepatitis C
  • Ezatiostat Hydrochloride: is an inhibitor of glutathione S-transferase P1-1, and is under investigation in the treatment of myelodysplastic syndrome
  • Ibrutinib: is an inhibitor of Bruton's tyrosine kinase that is used in the treatment of mantle cell lymphoma
  • Levomilnacipran: is the 1S,2R-enantiomer of milnacipran, a serotonin and noradrenaline reuptake inhibitor. It is used as the hydrochloride for the treatment of depression
  • Macitentan: is an endothelin receptor antagonist used in the management of pulmonary hypertension
  • Simeprevir: is an oral HCV-protease inhibitor that is used in a regimen with peginterferon alfa and ribavirin for the treatment of chronic hepatitis C genotype 1
  • Sofosbuvir: is an oral nucleotide analogue inhibitor that is used in a regimen with ribavirin, or with ribavirin and peginterferon, for the treatment of chronic hepatitis C genotypes 1, 2, 3, or 4
  • Sucroferric Oxyhydroxide: is a phosphate binder used for hyperphosphataemia in patients with chronic renal failure requiring haemodialysis

New salts or related derivatives: Nizofenone Fumarate, Pixantrone Maleate.

Notable revisions:

  • Infertility: updated guidelines from NICE and EAU
  • Malaria: updated guidelines from HPA Advisory Committee on Malaria Prevention
  • Septicaemia: updated BNF statement on treatment of community-acquired septicaemia
  • Nonsteroidal Anti-inflammatory Drugs: contraindications and warnings updated

Proprietary Preparations and Manufacturers updated for the following countries and regions: France†, Japan, UK†, USA† († Countries updated on an ongoing basis)


11 Dec 2013: Martindale December 2013 update

This update contains 6 new monographs, 148 existing monographs have been updated, and 3 treatment reviews re-validated. Pharmacopoeial information has been updated to reflect the USP 36 NF 31 Supplement 2, preparations updated for 9 countries, and Chinese character preparation names added.

New monographs:

  • Dabrafenib: is an inhibitor of BRAF kinases that is used for the treatment of unresectable or metastatic melanoma
  • Dolutegravir: is an HIV-integrase inhibitor that is used with other antiretrovirals for treatment of HIV infection and AIDS
  • Riociguat: is a guanylate cyclase stimulator used in the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
  • Spinosad: is an insecticide composed of a mixture of spinosad factor A and spinosad factor D in the ratio of about 5:1 and is used topically in the treatment of head lice. It is also used as an agricultural and horticultural insecticide
  • Trametinib: is an inhibitor of mitogen-activated extracellular kinases (MEK 1 and 2) that is used in the treatment of unresectable or metastatic melanoma
  • Vortioxetine: inhibits the reuptake of serotonin (5-HT) and is an antagonist at 5-HT3 and an agonist at 5-HT1A receptors. It is used in the treatment of depression

New salts or related derivatives: Esomeprazole Strontium, Lipegfilgrastim.

Notable revisions:

  • Idiopathic Thrombocytopenic Purpura: title changed to Immune Thrombocytopenia and treatment review updated
  • Non-small cell lung cancer: treatment review updated
  • Acute Lymphoblastic Leukaemia: treatment review updated
  • Paracetamol: updated advice on treatment of paracetamol poisoning
  • Aprotinin: marketing suspension lifted in EU and Canada
  • Vilanterol Trifenatate: Breo Ellipta (GSK) has its first marketing for COPD in US
  • Chapters on anthelmintics, antibacterials, and antiprotozoals: Medical Letter 2013 updates
  • Chapters on antifungals, antiprotozoals, and antivirals: US guidelines for opportunistic infections updated
  • Vaccines chapter: immunisation schedules revised and updated

Proprietary Preparations and Manufacturers updated for the following countries and regions: Finland, France†, Germany, Israel, Japan, Spain, UK†, Ukraine, USA† († Countries updated on an ongoing basis)


10 Sep 2013: Martindale 4th Quarter 2013 Update

Martindale updated with 62 revised and 4 new monographs

This quarter, 4 new monographs have been added and a further 62 existing monographs have been updated. In addition, 3 treatment reviews have been re-validated.

In addition, pharmacopoeial information in monographs has been updated to reflect the PhEur 7.8 and the USP 36 NF 31 Supplement 1. The Atomic Weights have also been updated.

Preparations have been updated for 7 countries, including the addition of over 6000 Chinese preparations.

Full details (PDF).


11 Jun 2013: Martindale 3rd Quarter 2013 Update

Martindale updated with 40 revised and 3 new monographs

This quarter, 3 new monographs have been added and a further 40 existing monographs have been updated.

In addition, pharmacopoeial information in monographs has been updated to reflect the PhEur 7.7. The ATC and ATCvet codes have also been updated.

Preparations have been updated for 7 countries.

Full details (PDF).


12 Mar 2013: Martindale 2nd Quarter 2013 Update

Martindale updated with 22 revised and 7 new monographs

This quarter, 7 new monographs have been added and a further 22 existing monographs have been updated.

In addition, for British Approved Names the spelling of the stem 'sulph' has been changed to 'sulf'. Pharmacopoeial information in monographs has also been updated to reflect the BP 2013, the BP (Vet) 2013, the PhEur 7.5 and 7.6, and the USP 36 and USNF 31.

Preparations have been updated for 7 countries.

Full details (PDF).


11 Dec 2012: Martindale 1st Quarter 2013 update

Martindale updated with 46 revised and 8 new monographs

This quarter, 8 new monographs have been added and a further 46 existing monographs have been updated.

Preparations have been updated for 6 countries.

Full details (PDF).


11 Sep 2012: Martindale 4th Quarter 2012 update

Martindale updated with 31 revised and 3 new monographs

This quarter, 3 new monographs have been added and a further 31 existing monographs have been updated. In addition, 7 treatment reviews have been re-validated.

Preparations have been updated for 6 countries.

Full details (PDF).


12 Jun 2012: Martindale 3rd Quarter 2012 update

Martindale updated with 77 revised and 2 new monographs

This quarter, 2 new monographs have been added and a further 77 existing monographs have been updated. In addition, 5 treatment reviews have been re-validated.

Preparations have been updated for 5 countries.

Full details (PDF).


22 Mar 2012: Martindale 2nd Quarter 2012 update

Martindale updated with 23 revised and 2 new monographs.

This quarter, 2 new monographs have been added and a further 23 existing monographs and treatment reviews have been updated.

In addition, atomic weights have been updated throughout the publication; pharmacopoeial information in monographs has also been updated to reflect the BP 2012, the BP (Vet) 2012, the PhEur 7.4 and the USP 35 and USNF 30.

Preparations have been updated for 4 countries.

Full details (PDF).


13 Dec 2011: Martindale 1st Quarter 2012 update

Martindale updated with 78 revised and 92 new monographs, plus 8 revised chapters or chapter sections.

This quarter, revision has been carried out on Anthelmintics, Antimalarials, General Anaesthetics, Growth Hormone and its Modulators, and also on sections of Antidiabetics, Cardiovascular Drugs, Chelators Antidotes and Antagonists, and Pharmaceutical Excipients.

In addition, 92 new monographs have been added and a further 78 existing monographs and treatment reviews have been updated. Precautions for Porphyria have been updated throughout the publication and Chinese, Greek and Japanese synonyms have also been added. Information on drugs restricted in sport has been updated for the WADA Prohibited List 2012.

Preparations have been updated for 12 countries.

Full details (PDF).


14 Sep 2011: Martindale 4th Quarter 2011 update

Martindale updated with 56 revised and 34 new monographs, plus 9 revised chapters or chapter sections.

This quarter, revision has been carried out on Antimigraine Drugs, Thyroid and Antithyroid Drugs, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Antibacterials, Antineoplastics, Antivirals, Anxiolytic Sedatives Hypnotics and Antipsychotics, Chelators Antidotes and Antagonists, and Pharmaceutical Excipients.

In addition, 34 new monographs have been added and a further 56 existing monographs and treatment reviews have been updated. Further UNII codes have also been added to monographs. Pharmacopoeial information in monographs throughout the publication has also been updated to reflect the PhEur 7.3 and the USP 34 and USNF 29 (including supplement 2).

Preparations have been updated for 9 countries.

Full details (PDF).


16 Jun 2011: Martindale 3rd Quarter 2011 update

Martindale updated with 62 revised and 34 new monographs, plus 14 revised chapters or chapter sections.

This quarter, revision has been carried out on Antimyasthenics and Obstetric Drugs, and also on sections of Antibacterials, Antidiabetics, Antineoplastics, Antivirals, Anxiolytics, Cardiovascular Drugs, and Chelators Antidotes and Antagonists.

In addition, 34 new monographs have been added and a further 62 existing monographs and treatment reviews have been updated. More UNII codes have also been added to monographs. Pharmacopoeial information in monographs throughout the publication has also been updated to reflect the PhEur 7.2 and the USP 34 and USNF 29 (including supplement 1).

Preparations have been updated for 10 countries.

For this update, we have introduced the first tranche of Japanese synonyms.

Full details (PDF).


15 Mar 2011: Martindale 2nd Quarter 2011 update

Martindale updated with 45 revised and 16 new monographs, plus 12 revised chapters or chapter sections.

This quarter, revision has been carried out on Antigout Drugs, Antiprotozoals and Radiopharmaceuticals, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Antibacterials, Anxiolytics, and Cardiovascular Drugs.

In addition, 16 new monographs have been added and a further 45 existing monographs and treatment reviews have been updated. More UNII codes have been added to monographs and the ATC and ATC(Vet) codes have updated. Pharmacopoeial information in monographs throughout the publication has also been updated to reflect the PhEur 7.1, BP 2011, BP(Vet) 2011, and updates in the 2nd supplement to the USP 33 and USNF 28.

Preparations have been updated for 8 countries.

For this update, we have introduced the first tranche of INNs in Arabic and in Chinese.

Full details (PDF).


13 Dec 2010: Martindale 1st Quarter 2011 update

Martindale updated with 26 new monographs, plus a new chapter section containing an additional 81 substances

This quarter, a new chapter section on `Additional Substances of Medical Interest' has been compiled of 81 substances that appear on the WADA Prohibited List and which do not appear elsewhere in Martindale.

In addition 21 other new monographs have been added to existing chapter sections and a further 53 monographs and treatment reviews have been updated. More UNII codes have been added to monographs and information on drugs restricted in sport has been updated for the WADA Prohibited List 2011. Pharmacopoeial information has also been updated to reflect the PhEur 7.0 in monographs throughout the publications.

Preparations have been updated for 7 countries

Full details (PDF).


27 Sep 2010: Martindale 4th quarter 2010 update

Martindale updated with 30 new monographs, plus 26 revised chapters or chapter sections

This quarter, revision has been carried out on Antidepressants, Blood Products Plasma Expanders and Haemostatics, Corticosteroids, Dermatological Drugs and Sunscreens, Disinfectants and Preservatives, General Anaesthetics, Local Anaesthetics, Miotics Mydriatics and Antiglaucoma Drugs, Muscle Relaxants, Neuromuscular Blockers, Pesticides and Repellents, Sex Hormones and their Modulators, and Vaccines Immunoglobulins and Antisera, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Cardiovascular Drugs, and Supplementary Drugs and Other Substances.

In addition, 30 new monographs and treatment reviews have been added.

Preparations have been updated for 5 countries.

Full details (PDF).

For this update, we have introduced an additional drug coding system: UNII (Unique Ingredient Identifier) codes, produced by the FDA as part of the FDA/USP Substance Registration System. These codes are intended to provide a unique and unambiguous identifier for substances in drugs, biologics, foods, and devices.


22 Jun 2010: Martindale 3rd quarter 2010 update

Martindale updated with 13 revised and 39 new monographs, plus 11 revised chapters or chapter sections

This quarter, revision has been carried out on Antifungals, Chelators Antidotes and Antagonists, Gases, Immunosuppressants, and Stimulants and Anorectics, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Antibacterials, Antineoplastics, Antivirals, Cardiovascular Drugs, and Supplementary Drugs and Other Substances.

In addition, 39 new monographs and treatment reviews have been added and a further 13 existing monographs and treatment reviews have been updated.

Preparations have been updated for 10 countries.

Full details (PDF).

For this update, we have introduced 2 additional drug coding systems: ATC codes for herbal medicines now complement the existing ATC codes for conventional and veterinary drugs; and Martindale's own unique identifiers, the Martindale codes.

The display of modification dates has been extended to most documents in Martindale. In the drug monographs, each major section now carries the date at which a change was last made. This is in addition to the revision dates currently displayed at the top of the monographs. Modification dates are also displayed in treatment reviews, preparations, and manufacturers records.

Another enhancement is to the way results are delivered when the search results are limited using the Sections or Interactions tabs. Rather than presenting the information within the full monograph, just the section requested is displayed. This should help to give a more focussed result and shorten document displays. Links to the complete monograph and to other sections are presented at the top of the document. Please let us know if you find this new presentation useful by using the Feedback form.


11 Mar 2010: Martindale 2nd quarter 2010 update

Martindale updated with 7 revised and 41 new monographs, plus 30 revised chapters or chapter sections

This quarter, revision has been carried out on Anthelmintics, Antiepileptics, Antihistamines, Antimalarials, Antiparkinsonian Drugs, Cough Suppressants Expectorants Mucolytics and Nasal Decongestants, Obstetric Drugs, Radiopharmaceuticals, and Stimulants and Anorectics, and also on sections of Analgesics Anti-inflammatory Drugs and Antipyretics, Antineoplastics, Antivirals, Cardiovascular Drugs, Pharmaceutical Excipients, Sex Hormones and their Modulators, and Supplementary Drugs and Other Substances.

In addition, 41 new monographs and treatment reviews have been added and a further 7 existing monographs and treatment reviews have been updated. Information on drugs in the Japanese Pharmacopoeia, 15th edition, ATC codes for veterinary drugs, and street names has been updated.

Preparations have also been updated for 7 countries.

Full details (PDF).


16 Dec 2009: Martindale 1st quarter 2010 update

Martindale updated with 18 revised and 48 new monographs, plus 43 revised chapters or chapter sections

This quarter, revision has been carried out on Antidiabetics and also on sections of Antibacterials, Antineoplastics, Anxiolytic Sedatives Hypnotics and Antipsychotics, Bronchodilators and Anti-Asthma Drugs, Cardiovascular Drugs, Gastrointestinal Drugs, Pharmaceutical Excipients, and Supplementary Drugs and Other Substances.

In addition, 48 new monographs have been added and a further 18 existing monographs and treatment reviews have been updated. Information on drugs restricted in sport has been updated for the WADA Prohibited List 2010.

Preparations have also been updated for 6 countries.

Full details (PDF).


10 Sep 2009: Martindale 4th quarter 2009 update

Martindale updated with 22 revised and 10 new monographs, plus 27 revised chapters or chapter sections

This quarter, revision has been carried out on Antiprotozoals, Contrast Media, Electrolytes, and Gases, and also on sections of Antibacterials, Antineoplastics, Anxiolytic Sedatives Hypnotics and Antipsychotics, Cardiovascular Drugs, Gastrointestinal Drugs, Pharmaceutical Excipients, and Supplementary Drugs and Other Substances.

In addition, 10 new monographs have been added and a further 22 existing monographs and treatment reviews have been updated.

Preparations have also been updated for 8 countries.

Full details (PDF).


17 Jun 2009: Martindale third quarter 2009 update

Martindale updated with 15 revised and 13 new monographs, plus 8 revised chapters or chapter sections

This quarter, revision has been carried out on Antimigraine Drugs, Bone Modulating Drugs, Growth Hormone and its Modulators, Nutritional Agents and Vitamins, and Thyroid and Antithyroid Drugs and also on sections of Antibacterials, Anxiolytic Sedatives Hypnotics and Antipsychotics, and Cardiovascular Drugs.

In addition, 13 new monographs have been added and a further 15 existing monographs and treatment reviews have been updated.

A new index entitled Pharmaceutical Terms in Various Languages has been included. It lists some of the commoner pharmaceutical forms and routes in English and a number of major European languages.

Preparations have also been updated for 9 countries.

Full details (PDF).


17 Mar 2009: Martindale second quarter 2009 update

Martindale updated with 14 revised and 9 new monographs, plus 6 chapters revised fully or in part, and updated product information for 9 countries.

This quarter, complete revision and revalidation has been carried out on Antidementia Drugs, Antigout Drugs, Antimyasthenics, and Urological Drugs, and also selected treatment reviews from Antibacterials and Cardiovascular Drugs. In addition, 9 new monographs have been added and a further 14 existing monographs and treatment reviews have been updated.

Preparations have also been updated for 9 countries.

Full details (PDF).


19 Dec 2008: Martindale first quarter 2009 update

Martindale updated with 22 revised and 12 new monographs, plus one fully revised chapter section, and updated product information for 10 countries.

This quarter, complete revision and revalidation of the information on Glycopeptide Antibacterials has been completed. A new chapter on Pharmaceutical Excipients has been created comprising relevant monographs from other existing chapters. In addition, 12 new monographs have been added and a further 22 existing monographs and treatment reviews have been updated.

Preparations have also been updated for 10 countries.

Full details (PDF).


19 Sep 2008: Martindale 4th quarter update

This quarter, 68 new monographs have been added and a further 11 have been updated, in addition to the completion of revision and revalidation of the complete database. A new feature allows easier identification of preparations with similar ingredients.

This quarter, revision and revalidation of the information on all chapters has been completed. In addition, 68 new monographs have been added and a further 11 existing monographs and treatment reviews have been updated.

Preparations have been updated for 6 countries.

A new feature added this quarter means that it is easier to identify multi-ingredient preparations with similar ingredients. The list of other preparations appears at the bottom of any multi-ingredient preparation record.

Full details (PDF).


12 Jun 2008: Martindale third quarter 2008 update

Martindale updated with 19 revised and 30 new monographs, plus 3 fully revised chapters, and updated product information for 8 countries.

This quarter, complete revision and revalidation of the information on Allergen Products, Angina Pectoris, Bronchodilators and Anti-asthma Drugs (complete chapter), Glatiramer Acetate, Glicofosfopeptical, Hypertension, Immunosuppressants (complete chapter), Myocardial Infarction, Nonionic Surfactants (complete chapter), Pneumonia, Reperfusion and Revascularisation, Thalidomide, and Valvular Heart Disease has been completed. In addition, 30 new monographs have been added and a further 9 existing monographs and treatment reviews have been updated.

Preparations have been updated for 8 countries including Indonesia which is new for this quarter.

Full details (PDF).


12 Mar 2008: Martindale second quarter 2008 update

Martindale updated with 50 revised and 45 new monographs, plus 4 fully revised chapter sections, and updated product information for 6 countries.

This quarter, 45 new monographs have been added and 50 existing monographs and treatment reviews have been updated, plus complete revision and revalidation of the information on miscellaneous Antibacterials, Beta Blockers, Hormonal Contraceptives and Hormone Replacement Therapy, and some Biologicals. Preparations have also been updated for 6 countries.

Full details (PDF).


14 Dec 2007: Martindale first quarter 2008 update

Martindale updated with 66 revised and 28 new monographs, including 5 fully revised chapters, and product information updated for 10 countries

This quarter, 28 new monographs have been added and 66 existing monographs and treatment reviews have been updated, including complete revision and revalidation of the information on Androgens and Anabolics, Antimycobacterials, Dermatological Drugs and Sunscreens, Nonsteroidal Anti-inflammatory Drugs, and Paraffins and Similar Bases. Preparations have also been updated for 10 countries.

We have added an alphabetical list of disease treatment reviews to the table of contents to make them easier to find.

Full details (PDF).


14 Nov 2007: Your views sought - please complete our 5 minute survey

MedicinesComplete User Survey - RPS Publishing is seeking important input from their customers

We are evaluating MedicinesComplete and value your input. The survey will focus on your experience at MedicinesComplete.com, its products, and other related areas (content, features, etc).

We invite you to complete this short 5 minute survey that can be accessed via the following link:

Please click here

Please be assured that your responses will be kept completely confidential within our organisation.

We ask that you please complete the survey no later than November 30, 2007.

Thank you for your time and participation.

The MC Digital Team at RPS Publishing

29 Aug 2007: Martindale fourth quarter 2007 update

Martindale updated with 105 revised and 19 new monographs, including 2 fully revised chapters, and product information updated for 9 countries

This quarter, 19 new monographs have been added and 105 existing monographs and treatment reviews have been updated, including complete revision and revalidation of the information on lincosamides in the chapter on Antibacterials and antiarrythmics in the chapter on Cardiovascular Drugs. Preparations have also been updated for 9 countries, including the Philippines and Poland, both new for this quarter.

Full details (PDF).


19 Jun 2007: Martindale third quarter 2007 update

Revised chapters, monographs, and product information

This quarter, 6 chapters or chapter sections have been completely revised and revalidated, 31 new monographs have been added, and 55 existing monographs and treatment reviews have been updated. Preparations have also been updated for 6 countries.

Drug monographs are now listed alphabetically in the contents list under Drugs and Ancillary Substances as well as by therapeutic use.

Full details (PDF).


21 Mar 2007: Martindale second quarter 2007 update

Revised chapters, monographs, and product information

This quarter, 5 chapters or chapter sections have been completely revised and revalidated, 21 new monographs have been added, and 40 existing monographs and treatment reviews have been updated. Preparations have also been updated for 8 countries.

Chapters on Prostaglandins and Hypothalamics have been reorganised and their contents added to new chapters on Obstetric Drugs and Growth Hormone and its Modulators.

A new printable User's Guide is now available to download from the Martindale home page.

Full details (PDF).


15 Dec 2006: Martindale first quarter 2007 update

Revised chapters, monographs, and product information

This quarter, information on miscellaneous analgesics, anti-inflammatory drugs, and antipyretics has been completely revised and revalidated, 63 new monographs have been added, and 76 existing monographs and treatment reviews have been updated. Preparations and manufacturer information from 12 countries has been updated, including Turkey, new for this quarter.

Full details (PDF).


25 Sep 2006: Martindale fourth quarter 2006 update

Revised chapters, monographs, and product information

This quarter, 46 chapters have been revised, 72 new monographs have been added, 1 new treatment review has been added, and a further 4 monographs have been updated.

Full details (PDF).


19 Jun 2006: Martindale third quarter 2006 update

Revised chapters, monographs, and product information

This quarter, eight chapters have been completely revised and revalidated, 10 new monographs have been added, 3 new treatment reviews have been added, and a further 6 monographs have been updated.

Full details (PDF).


23 Mar 2006: Martindale second quarter 2006 update

Martindale updated with new and revised monographs and new product information

This quarter, eight chapters or chapter sections have been completely revised and revalidated, 19 new monographs have been added, 3 new treatment reviews have been added, 1 new country has been added and preparations for a further 7 countries have been updated, and 31 monographs have been updated.

Full details (PDF).


15 Dec 2005: Martindale first quarter 2006 update

Martindale updated with new and revised monographs and new product information

This quarter, five chapters have been completely revised and revalidated, 39 new monographs and 7 new treatment reviews have been added, and a further 80 monographs have been updated. Preparations have been updated for 9 countries. In addition, pharmacopoeial information has been updated to reflect the BP 2005, USP 29, USNF 24, PhEur 5.4, and Ger.P. 2005 in monographs throughout the publication.

Full details (PDF).


11 Oct 2005: Martindale fourth quarter update

New and revised information, and more international names now available in Martindale

This quarter, one chapter has been completely revised and revalidated, 13 new monographs have been added, and a further 67 monographs have been updated. We have also added structural formulae to many monographs and now include the International Nonproprietary Names in Spanish, French, Russian, and Latin as well as English. ATC codes have been added to the table of contents to give another way to find information.

Full details (PDF).


28 Jun 2005: Martindale third quarter update

Revised chapters, monographs, and product information

The June update contains 2 completely re-evaluated chapters, 11 new drug monographs, updates to a further 97 drug and treatment monographs, and updated proprietary product information for 9 countries.

Full details (PDF).


27 May 2005: Martindale quarterly update

Revised chapters, monographs and product information.

The March update contains 2 completely re-evaluated chapters, 19 new drug monographs, updates to a further 74 drug and treatment monographs, and updated proprietary product information for 10 countries.